Prevalence of cervical disease at age 20 after immunisation with bivalent HPV vaccine at age 12-13 in Scotland: retrospective population study

High Effectiveness of the Bivalent Human Papillomavirus (HPV) Vaccine Against Incident and Persistent HPV Infections up to 6 Years After Vaccination in Young Dutch Women

(2018) R Donken et al.   JOURNAL OF INFECTIOUS DISEASES

Changes in the prevalence of human papillomavirus following a national bivalent human papillomavirus vaccination programme in Scotland: a 7-year cross-sectional study

(2017) Kimberley Kavanagh et al.   LANCET INFECTIOUS DISEASES

HPV immunisation and cervical screening—confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study

(2016) T J Palmer et al.   BRITISH JOURNAL OF CANCER

HPV immunisation and increased uptake of cervical screening in Scottish women; observational study of routinely collected national data

(2016) T J Palmer et al.   BRITISH JOURNAL OF CANCER

Impact and Effectiveness of the Quadrivalent Human Papillomavirus Vaccine: A Systematic Review of 10 Years of Real-world Experience

(2016) Suzanne M. Garland et al.   CLINICAL INFECTIOUS DISEASES

Use of HPV testing for cervical screening in vaccinated women-Insights from the SHEVa (Scottish HPV Prevalence in Vaccinated Women) study

(2016) Ramya Bhatia et al.   INTERNATIONAL JOURNAL OF CANCER

Quadrivalent HPV vaccine effectiveness against high-grade cervical lesions by age at vaccination: A population-based study

(2016) Eva Herweijer et al.   INTERNATIONAL JOURNAL OF CANCER

Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus

(2016) Jane J. Kim et al.   JNCI-Journal of the National Cancer Institute

Optimal Cervical Cancer Screening in Women Vaccinated Against Human Papillomavirus

(2016) Jane J. Kim et al.   JNCI-Journal of the National Cancer Institute

The Pap Test and Bethesda 2014

(2015) Ritu Nayar et al.   ACTA CYTOLOGICA

The Early Benefits of Human Papillomavirus Vaccination on Cervical Dysplasia and Anogenital Warts

(2015) L. M. Smith et al.   PEDIATRICS

Impact of 2-, 4- and 9-valent HPV vaccines on morbidity and mortality from cervical cancer

(2015) Rebecca Luckett et al.   Human Vaccines & Immunotherapeutics

Introduction and sustained high coverage of the HPV bivalent vaccine leads to a reduction in prevalence of HPV 16/18 and closely related HPV types

(2014) K Kavanagh et al.   BRITISH JOURNAL OF CANCER

Reduction of low- and high-grade cervical abnormalities associated with high uptake of the HPV bivalent vaccine in Scotland

(2014) K G J Pollock et al.   BRITISH JOURNAL OF CANCER

Type-specific HPV prevalence in invasive cervical cancer in the UK prior to national HPV immunisation programme: baseline for monitoring the effects of immunisation

(2014) David Mesher et al.   JOURNAL OF CLINICAL PATHOLOGY

Early Impact of Human Papillomavirus Vaccination on Cervical Neoplasia--Nationwide Follow-up of Young Danish Women

(2014) B. Baldur-Felskov et al.   JNCI-Journal of the National Cancer Institute

Evidence for Frequent Regression of Cervical Intraepithelial Neoplasia–Grade 2

(2014) Philip E. Castle et al.   OBSTETRICS AND GYNECOLOGY

Estimation of HPV prevalence in young women in Scotland; monitoring of future vaccine impact

(2013) Kimberley Kavanagh et al.   BMC INFECTIOUS DISEASES

Impact of a population-based HPV vaccination program on cervical abnormalities: a data linkage study

(2013) Dorota M Gertig et al.   BMC Medicine

Declining Rates of High-Grade Cervical Lesions in Young Women in Connecticut, 2008-2011

(2013) L. M. Niccolai et al.   CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION

Achieving high and equitable coverage of adolescent HPV vaccine in Scotland

(2013) Katy Sinka et al.   JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH

Changes in sexual attitudes and lifestyles in Britain through the life course and over time: findings from the National Surveys of Sexual Attitudes and Lifestyles (Natsal)

(2013) Catherine H Mercer et al.   LANCET

Evaluation of type-specific HPV persistence and high-risk HPV viral load quantitation in HPV positive women under 30 with normal cervical cytology

(2011) Xavier Carcopino et al.   JOURNAL OF MEDICAL VIROLOGY

Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study

(2011) Julia ML Brotherton et al.   LANCET

The proposed BSCC terminology for abnormal cervical cytology

(2008) Karin Denton   CYTOPATHOLOGY